Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander M Walker

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Pharmacoepidemiology and Drug Safety|June 9, 2006
The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapyAndrew T McAfee, Eileen E Ming, John D Seeger, et al.
Pharmacoepidemiology and Drug Safety|May 31, 2006
Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programmeSaga Johansson, Eileen E Ming, Mari-Ann Wallander, et al.
Pharmacoepidemiology and Drug Safety|October 29, 2008
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine StudyPriscilla Velentgas, Rhonda L Bohn, Jeffrey S Brown, et al.
Pharmacoepidemiology and Drug Safety|May 13, 2022
The acute effects of azithromycin use on cardiovascular mortality as compared with amoxicillin-clavulanate in US VeteransMaral DerSarkissian, Yinong Young-Xu, Mei Sheng Duh, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2014
Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systemsCarlos Bell, Aloka Chakravarty, Susan Gruber, et al.
Pharmacoepidemiology and Drug Safety|December 29, 2006
Asthma drug use and the development of Churg-Strauss syndrome (CSS)Leslie R Harrold, M Kay Patterson, Susan E Andrade, et al.
The Journal of Sexual Medicine|November 1, 2014
Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitorsUlka B Campbell, Alexander M Walker, Michael Gaffney, et al.
The Journal of Antimicrobial Chemotherapy|July 14, 2016
Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort studySebastian Schneeweiss, Peggy L Carver, Kausik Datta, et al.
The Journal of Antimicrobial Chemotherapy|October 4, 2019
Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungalsSebastian Schneeweiss, Peggy L Carver, Kausik Datta, et al.
Pharmacoepidemiology and Drug Safety|July 19, 2012
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccinationPriscilla Velentgas, Anthony A Amato, Rhonda L Bohn, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Pharmacoepidemiology and Drug Safety|June 9, 2006
The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapyAndrew T McAfee, Eileen E Ming, John D Seeger, et al.
Pharmacoepidemiology and Drug Safety|May 31, 2006
Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programmeSaga Johansson, Eileen E Ming, Mari-Ann Wallander, et al.
Pharmacoepidemiology and Drug Safety|October 29, 2008
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine StudyPriscilla Velentgas, Rhonda L Bohn, Jeffrey S Brown, et al.
Pharmacoepidemiology and Drug Safety|May 13, 2022
The acute effects of azithromycin use on cardiovascular mortality as compared with amoxicillin-clavulanate in US VeteransMaral DerSarkissian, Yinong Young-Xu, Mei Sheng Duh, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2014
Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systemsCarlos Bell, Aloka Chakravarty, Susan Gruber, et al.
Pharmacoepidemiology and Drug Safety|December 29, 2006
Asthma drug use and the development of Churg-Strauss syndrome (CSS)Leslie R Harrold, M Kay Patterson, Susan E Andrade, et al.
The Journal of Sexual Medicine|November 1, 2014
Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitorsUlka B Campbell, Alexander M Walker, Michael Gaffney, et al.
The Journal of Antimicrobial Chemotherapy|July 14, 2016
Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort studySebastian Schneeweiss, Peggy L Carver, Kausik Datta, et al.
The Journal of Antimicrobial Chemotherapy|October 4, 2019
Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungalsSebastian Schneeweiss, Peggy L Carver, Kausik Datta, et al.
Pharmacoepidemiology and Drug Safety|July 19, 2012
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccinationPriscilla Velentgas, Anthony A Amato, Rhonda L Bohn, et al.
Pageof 12